Chemical, Biological, Radiological, and Nuclear Threats: Countermeasure Preparation ( Terrorism, Hot Spots and Conflict-Related Issues )

Publication series :Terrorism, Hot Spots and Conflict-Related Issues

Author: Anna J. Clemens;Marcel P. Nielsen  

Publisher: Nova Science Publishers, Inc.‎

Publication year: 2016

E-ISBN: 9781619425330

P-ISBN(Paperback): 9781619425194

Subject: L No classification

Keyword: 暂无分类

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Chemical, Biological, Radiological, and Nuclear Threats: Countermeasure Preparation

Chapter

HHS HAS BEGUN TO ADDRESS MOST OF ITS OWN RECOMMENDATIONS WITH INITIATIVES INTENDED TO IMPROVE MEDICAL COUNTERMEASURE ACTIVITIES, BUT DOES NOT HAVE AN ADEQUATE STRATEGY TO MONITOR IMPLEMENTATION

HHS Agencies and Offices Have Begun to Address Most of HHS’s Recommendations with Initiatives Intended to Improve PHEMCE and Its Medical Countermeasure Activities

HHS Has Gathered Information on Agencies’ and Offices’ Implementation of the Initiatives but Has Not Developed an Adequate Strategy to Monitor Overall Progress

HHS’S PHEMCE AND RELATED WRITTEN AGREEMENTS HAVE FACILITATED INTRADEPARTMENTAL COORDINATION, BUT CHALLENGES REMAIN THAT MAY BE ADDRESSED THROUGH HHS’S NEW INITIATIVES

HHS’s PHEMCE Structure and Related Written Agreements Have Facilitated Intradepartmental Coordination

Industry and Outside Experts Indicate That New Initiatives May Mitigate Some Coordination Challenges

CONCLUSION

RECOMMENDATIONS FOR EXECUTIVE ACTION

AGENCY COMMENTS AND OUR EVALUATION

APPENDIX I: HHS MEDICAL COUNTERMEASURE DEVELOPMENT AND ACQUISITION PRIORITIES AND INVESTMENTS

APPENDIX II: HHS INITIATIVES TO ADDRESS ITS RECOMMENDATIONS TO IMPROVE MEDICAL COUNTERMEASURE ACTIVITIES

End Notes

End Notes for Appendix I

End Notes for Appendix II

Chapter 2 NATIONAL PREPAREDNESS: DHS AND HHS CAN FURTHER STRENGTHEN COORDINATION FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR RISK ASSESSMENTS

WHY GAO DID THIS STUDY

WHAT GAO RECOMMENDS

WHAT GAO FOUND

ABBREVIATIONS

BACKGROUND

DHS AND HHS COORDINATE ON THE DEVELOPMENT OF CBRN RISK ASSESSMENTS BUT DO NOT HAVE WRITTEN PROCEDURES FOR THEIR DEVELOPMENT

DHS Coordination with HHS on the Development of Its CBRN Risk Assessments Has Varied, and DHS Has Not Yet Established Related Written Procedures

HHS Signed an Interagency Agreement and Coordinates with DHS to Develop Modeling Reports but Does Not Have Written Procedures for Their Development

CONCLUSION

RECOMMENDATIONS FOR EXECUTIVE ACTION

AGENCY COMMENTS AND OUR EVALUATION

APPENDIX I: DHS AND HHS CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR RISK ASSESSMENTS

Risk and Risk Assessment

DHS and HHS CBRN Risk Assessments

DHS Terrorism Risk Assessments

DHS Material Threat Assessments

HHS Public Health and Medical Consequence Modeling Reports

End Notes

End Notes for Appendix I

Chapter 3 STATEMENT OF GUS M. BILIRAKIS, CHAIRMAN OF SUBCOMMITTEE ON EMERGENCY PREPAREDNESS, RESPONSE AND COMMUNICATIONS. HEARING ON “TAKING MEASURE OF COUNTERMEASURES(PART 1): A REVIEW OF GOVERNMENT AND INDUSTRY EFFORTS TO PROTECT THE HOMELAND THROUGH ACCELERATED RESEARCH, DEVELOPMENT, AND ACQUISITION OF CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR MEDICAL COUNTERMEASURES

Chapter 4 STATEMENT OF RICHARD J. HATCHETT, CHIEF MEDICAL OFFICER AND DEPUTY DIRECTOR FOR STRATEGIC SCIENCES AND MANAGEMENT, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. HEARING ON “TAKING MEASURE OF COUNTERMEASURES (PART 1): A REVIEW OF GOVERNMENT AND INDUSTRY EFFORTS TO PROTECT THE HOMELAND THROUGH ACCELERATED RESEARCH, DEVELOPMENT, AND ACQUISITION OF CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR MEDICAL COUNTERMEASURES”

INTRODUCTION - ASPR/BARDA MISSION

THE PUBLIC HEALTH EMERGENCY MEDICAL COUNTERMEASURE ENTERPRISE

PHEMCE MCM Requirement-Setting Process

Project BioShield MCM Procurements

Advanced Research and Development

Integrated Portfolio for CBRN Medical Countermeasures

BARDA TechWatch Program

MEDICAL COUNTERMEASURE ENTERPRISE REVIEW

MCM DISTRIBUTION - EXECUTIVE ORDER 13527

CONCLUSION

Chapter 5 STATEMENT OF DR. GERALD W. PARKER, JR., DEPUTY ASSISTANT TO THE SECRETARY OF DEFENSE FOR CHEMICAL AND BIOLOGICAL DEFENSE. HEARING ON “TAKING MEASURE OF COUNTERMEASURES (PART 1): A REVIEW OF GOVERNMENT AND INDUSTRY EFFORTS TO PROTECT THE HOMELAND THROUGH ACCELERATED RESEARCH, DEVELOPMENT, AND ACQUISITIONCHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR MEDICAL COUNTERMEASURES”

INTRODUCTION

CHALLENGES TO PROGRESS ON MEDICAL COUNTERMEASURES

INTEGRATED BIODEFENSE APPROACH

Detection and Initial Response

Medical Countermeasures Discovery and Development

Advanced Development and Manufacturing

INTERAGENCY COLLABORATION

CONCLUSION

Chapter 6 TESTIMONY OF PHYLLIS ARTHUR, SENIOR DIRECTOR FOR VACCINES, IMMUNOTHERAPEUTICS AND DIAGNOSTICS POLICY AT THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO). HEARING ON “TAKING MEASURE OF COUNTERMEASURES(PART 1): A REVIEW OF GOVERNMENT AND INDUSTRY EFFORTS TO PROTECT THE HOMELAND THROUGH ACCELERATED RESEARCH, DEVELOPMENT, AND ACQUISITION OF CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR MEDICAL COUNTERMEASURES”

Chapter 7 TESTIMONY OF JOHN M. CLERICI, ESQ., PRINCIPAL, TIBER CREEK PARTNERS, LLC. HEARING ON “TAKING MEASURE OF COUNTERMEASURES(PART 1): A REVIEW OF GOVERNMENT AND INDUSTRY EFFORTS TO PROTECT THE HOMELAND THROUGH ACCELERATED RESEARCH, DEVELOPMENT, AND ACQUISITION OF CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR MEDICAL COUNTERMEASURES”

Chapter 8 TESTIMONY OF DANIEL B. FAGBUYI, MD, FAAP, AMERICAN ACADEMY OF PEDIATRICS. HEARING ON “TAKING MEASURE OF COUNTERMEASURES(PART 1): A REVIEW OF GOVERNMENT AND INDUSTRY EFFORTS TO PROTECT THE HOMELAND THROUGH ACCELERATED RESEARCH, DEVELOPMENT, AND ACQUISITION OF CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR MEDICAL COUNTERMEASURES”

CHILDREN ARE MORE VULNERABLE THAN ADULTS

CHILDREN HAVE UNIQUE TREATMENT NEEDS

CHILDREN NEED CARE FROM PROVIDERS TRAINED TO MEET THEIR UNIQUE NEEDS

EMERGENCY MEDICAL SERVICES FOR CHILDREN

NATIONAL COMMISSION ON CHILDREN AND DISASTERS

MEDICAL PRODUCTS FOR CHILDREN

MEDICAL COUNTERMEASURES FOR CHILDREN

OTHER POLICY RECOMMENDATIONS

CONCLUSION

End Notes

Chapter 9 STATEMENT OF GUS M. BILIRAKIS, CHAIRMAN OF SUBCOMMITTEE ON EMERGENCY PREPAREDNESS, RESPONSE AND COMMUNICATIONS. HEARING ON "TAKING MEASURE OF COUNTERMEASURES(PART 2): A REVIEW OF EFFORTS TO PROTECT THE HOMELAND THROUGH DISTRIBUTION AND DISPENSING OF CBRN MEDICAL COUNTERMEASURES"

Chapter 10 STATEMENT OF ALEXANDER G. GARZA, MD, MPH, ASSISTANT SECRETARY FOR HEALTH AFFAIRS AND CHIEF MEDICAL OFFICER, U.S. DEPARTMENT OF HOMELAND SECURITY. HEARING ON "TAKING MEASURE OF COUNTERMEASURES (PART 2): A REVIEW OF EFFORTS TO PROTECT THE HOMELAND THROUGH DISTRIBUTION AND DISPENSING OF CBRN MEDICAL COUNTERMEASURES"

OHA INITIATIVES THAT HELP MITIGATE BIOLOGICAL THREATS AND HELP PREPARE THE NATION TO QUICKLY DETECT AND RESPOND TO BIOLOGICAL EVENTS

DHS ASSISTS AND COORDINATES WITH STATE AND LOCAL GOVERNMENTS

EXECUTIVE ORDER 13527: ESTABLISHING FEDERAL CAPABILITY FOR THE TIMELY PROVISION OF MEDICAL COUNTERMEASURES FOLLOWING A BIOLOGICAL ATTACK

DHS WORKFORCE AND HEALTH PROTECTION

CONCLUSION

Chapter 11 TESTIMONY OF ALI S. KHAN, ASSISTANT SURGEON GENERAL, U.S. PUBLIC HEALTH SERVICE, AND DIRECTOR, OFFICE OF PUBLIC HEALTH PREPAREDNESS AND RESPONSE, DEPARTMENT OF HEALTH AND HUMAN SERVICES. HEARING ON "TAKING MEASURE OF COUNTERMEASURES (PART 2): A REVIEW OF EFFORTS TO PROTECT THE HOMELAND THROUGH DISTRIBUTION AND DISPENSING OF CBRN MEDICAL COUNTERMEASURES"

INTRODUCTION

BACKGROUND

IMPORTANCE OF STATE AND LOCAL PARTNERSHIPS

FEDERAL PARTNER COLLABORATION

PHEMCE RECOMMENDATIONS GUIDE SNS PROCUREMENTS

CHALLENGES TO MAINTAINING A STRONG, FLEXIBLE SYSTEM

CONCLUSION

End Note

Chapter 12 TESTIMONY OF DAVID STARR, DIRECTOR OF COUNTERMEASURES RESPONSE, OFFICE OF EMERGENCY PREPAREDNESS AND RESPONSE, NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE. HEARING ON "TAKING MEASURE OF COUNTERMEASURES (PART 2): A REVIEW OF EFFORTS TO PROTECT THE HOMELAND THROUGH DISTRIBUTION AND DISPENSING OF CBRN MEDICAL COUNTERMEASURES"

Chapter 13 STATEMENT OF MIKE MCHARGUE, DIRECTOR, PUBLIC HEALTH & MEDICAL PLANNING & RESPONSE, FLORIDA DEPARTMENT OF HEALTH. HEARING ON "TAKING MEASURE OF COUNTERMEASURES (PART 2): A REVIEW OF EFFORTS TO PROTECT THE HOMELAND THROUGH DISTRIBUTION AND DISPENSING OF CBRN MEDICAL COUNTERMEASURES"

STATE LEVEL OVERVIEW

PUBLIC HEALTH SYSTEM

EMERGENCY MANAGEMENT STRUCTURE

DOMESTIC SECURITY STRUCTURE

MONITORING AND DETECTION OF THE THREAT

POPULATIONS AFFECTED

EVALUATIONS AND RECOMMENDATIONS FOR COUNTERMEASURES

INFORMATION MANAGEMENT BRANCH

POINTS OF DISPENSING (POD) STRATEGY

LOGISTICS ANNEX

STRATEGIC NATIONAL STOCKPILE (SNS)

CITIES READINESS INITIATIVE (CRI)

CHEMPACK

Chapter 14 STATEMENT OF LAWRENCE E. TAN, CHIEF OF EMERGENCY MEDICAL SERVICES, NEW CASTLE COUNTY, DELAWARE. HEARING ON "TAKING MEASURE OF COUNTERMEASURES (PART 2): A REVIEW OF EFFORTS TO PROTECT THE HOMELAND THROUGH DISTRIBUTION AND DISPENSING OF CBRN MEDICAL COUNTERMEASURES"

INTRODUCTION

Chapter 15 TESTIMONY OF JEFFREY LEVI, PHD, EXECUTIVE DIRECTOR, TRUST FOR AMERICA'S HEALTH. HEARING ON "TAKING MEASURE OF COUNTERMEASURES (PART 2): A REVIEW OF EFFORTS TO PROTECT THE HOMELAND THROUGH DISTRIBUTION AND DISPENSING OF CBRN MEDICAL COUNTERMEASURES"*

WORKFORCE AND INFRASTRUCTURE GAP

SURGE CAPACITY GAP

SURVEILLANCE GAP

COMMUNITY RESILIENCY SUPPORT GAP

GAPS IN MEDICAL COUNTERMEASURE ENTERPRISE

SUCCESS AT RISK: THE URBAN-RURAL EXPERIENCE

End Notes

INDEX

The users who browse this book also browse


No browse record.